IndustriesBiotechnologyHealth CarePharmaceuticalTherapeutics Diversity Spotlight (US Only)Women Founded Headquarters Regions Greater San Diego Area, West Coast, Western US Founded Date Oct 8, 2013 Founders J. Jean Cui, Y. Peter Li Operating Status Active Last Funding Type Post-IPO Equity Also Known As TP Therapeutics, Turning Point Tx Legal Name TP Therapeutics, Inc. Stock Symbol NASDAQ:TPTX Company Type For Profit Contact Email email@example.com Phone Number (858)926-5251
Turning Point Therapeutics is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. They focus on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential
targets regulating the tumor microenvironment and tumor immunity.
Transaction NameTurning Point Therapeutics acquired by Bristol Myers Squibb Acquired byBristol Myers Squibb Announced Date Jun 3, 2022 Price $4.1B